# A Crossover Safety Study of Ferumoxytol Versus Placebo

> **NCT00255450** · PHASE3 · COMPLETED · sponsor: **AMAG Pharmaceuticals, Inc.** · enrollment: 750 (—)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** ferumoxytol or placebo

## Key facts

- **NCT ID:** NCT00255450
- **Lead sponsor:** AMAG Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2006-08
- **Target enrollment:** 750 (—)
- **Last updated:** 2008-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255450, "A Crossover Safety Study of Ferumoxytol Versus Placebo". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT00255450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*